フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
GSK PLC 19 November 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA...
GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a trea ...
GSK PLC 19 November 2024 Issued: 19 November 2024, London UK Linerixibat shows positive Phase III results in cholestatic pruritus...
GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory ...
GSK PLC 14 November 2024 Issued: 14 November 2024, London UK Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial...
GSK PLC 13 November 2024 BLOCK LISTING SIX MONTHLY RETURN Date: 13 November 2024 Name of applicant: GSK plc Name of scheme:...
GSK PLC 12 November 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC 11 November 2024 GSK plc GSK publishes provisional dividend dates GSK announces the following dividend dates for 2025: These...
The following is a round-up of share dealings by London-listed company directors and managers announced in the past w ...
GSK PLC 01 November 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance...
GSK PLC 30 October 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC on Wednesday backed its full-year guidance following "another quarter of sales and core operating profit grow ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約